NasdaqGS - Nasdaq Real Time Price USD

Walgreens Boots Alliance, Inc. (WBA)

Compare
8.72 +0.05 (+0.58%)
At close: 4 October at 4:00 pm GMT-4
8.75 +0.03 (+0.34%)
After hours: 4 October at 7:59 pm GMT-4
Loading Chart for WBA
DELL
  • Previous close 8.67
  • Open 8.83
  • Bid 8.71 x 19200
  • Ask 8.75 x 9300
  • Day's range 8.71 - 8.93
  • 52-week range 8.22 - 27.05
  • Volume 16,059,676
  • Avg. Volume 19,523,162
  • Market cap (intra-day) 7.528B
  • Beta (5Y monthly) 0.68
  • PE ratio (TTM) --
  • EPS (TTM) -6.74
  • Earnings date 15 Oct 2024
  • Forward dividend & yield 1.00 (11.47%)
  • Ex-dividend date 21 Aug 2024
  • 1y target est 11.39

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

www.walgreensbootsalliance.com

206,000

Full-time employees

31 August

Fiscal year ends

Healthcare

Sector

Pharmaceutical Retailers

Industry

Recent news: WBA

View more

Performance overview: WBA

Trailing total returns as of 04/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD return

WBA
64.94%
S&P 500
20.57%

1-year return

WBA
58.44%
S&P 500
35.98%

3-year return

WBA
77.85%
S&P 500
31.99%

5-year return

WBA
78.68%
S&P 500
97.59%

Compare to: WBA

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: WBA

View more

Valuation measures

As of 04/10/2024
  • Market cap

    7.53B

  • Enterprise value

    39.50B

  • Trailing P/E

    --

  • Forward P/E

    4.08

  • PEG ratio (5-yr expected)

    --

  • Price/sales (ttm)

    0.05

  • Price/book (mrq)

    0.55

  • Enterprise value/revenue

    0.27

  • Enterprise value/EBITDA

    --

Financial highlights

Profitability and income statement

  • Profit margin

    -3.99%

  • Return on assets (ttm)

    1.30%

  • Return on equity (ttm)

    -55.97%

  • Revenue (ttm)

    145.53B

  • Net income avi to common (ttm)

    -5.81B

  • Diluted EPS (ttm)

    -6.74

Balance sheet and cash flow

  • Total cash (mrq)

    711M

  • Total debt/equity (mrq)

    218.17%

  • Levered free cash flow (ttm)

    2.17B

Research analysis: WBA

View more

Earnings per share

Consensus EPS
 

Revenue vs. Earnings

Revenue 36.35B
Earnings 344M
 

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analysts' price targets

7.00
11.39 Average
8.72 Current
19.00 High
 

People also watch